Cancer Genetics
Geisinger Health System Wins $3.6M NIH Grant to Study Genetics of Cancer Risk
The health system will partner with the NCI to look for new cancer risk variants in a large population biobank, in the hopes of improving screening and care.
Cancer Genetics to Sell $17.5M in Common Stock Through Direct Offering
The New Jersey-based cancer drug-discovery services provider said it had signed agreements to sell the shares to unnamed institutional investors.
Cancer Genetics to Raise $10M in Private Placement
The firm plans to use the net proceeds for general corporate purposes, including working capital and capital expenditures.
Cancer Genetics Q3 Revenues Down 24 Percent
The drug discovery and preclinical oncology services provider attributed the revenue decline to the impact of the SARS-CoV-2 pandemic on its customers.
Cancer Genetics to Acquire Organoid Startup Stemonix
Maple Grove, Minnesota-based Stemonix will merge in an all-equity transaction with a newly formed subsidiary of Cancer Genetics, which expects to remain listed on the Nasdaq.